Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerRobert L. Ferris, Athanassios Argiris, Dwight E. Heron et al.|Annals of Oncology|2016Cited by 34
Correlation of anti-tumor adaptive immunity with clinical response in a phase II “Window” trial of neoadjuvant cetuximab in patients with resectable stage III-IV head and neck squamous carcinoma (HNSCC).Robert L. Ferris, Julie E. Bauman, Seungwon Kim et al.|Journal of Clinical Oncology|2016Cited by 9